Combination Therapy for Coccidioidomycosis
Author Information
Author(s): Park Dae Won, Sohn Jang Wook, Cheong Hee Jin, Kim Woo Joo, Ja Kim Min, Kim Je Hyeong, Shin Chol
Primary Institution: Korea University College of Medicine
Hypothesis
Can combination therapy with caspofungin and fluconazole effectively treat diffuse coccidioidal pneumonia in an immunocompetent patient who does not respond to amphotericin B?
Conclusion
Combination therapy with caspofungin and fluconazole may be an effective alternative treatment for diffuse coccidioidal pneumonia that does not respond to standard therapy.
Supporting Evidence
- The patient initially did not respond to amphotericin B therapy.
- After switching to caspofungin and fluconazole, the patient showed significant clinical improvement.
- The patient's CF antibody titre decreased from 1:64 to undetectable levels after treatment.
Takeaway
A man with a serious lung infection got better after doctors used two medicines together instead of the usual one that wasn't working.
Methodology
The patient was treated with amphotericin B initially, followed by a combination of caspofungin and fluconazole after the initial treatment failed.
Limitations
The study is based on a single case report, limiting the generalizability of the findings.
Participant Demographics
31-year-old Korean male, immunocompetent.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website